HC Wainwright & Co. Maintains Buy on Biora Therapeutics, Adjusts Price Target To $23 (1-10 Reverse Stock Split)

BenzingaNov 19 02:00 · Ratings

Biora Therapeutics Faces Nasdaq Delisting Challenges

TipRanksNov 16 05:32

Biora Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness Following a Q3 Earnings Miss and a Year-over-year Decline in Revenue Reported on Thursday

BenzingaNov 16 04:31

Biora Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:17 · Announcements

Biora Therapeutics Q3 2024 GAAP EPS From Continuing Operations $(6.08) May Not Be Comparable To $(3.85) Estimate, Sales $32.00K Miss $210.00K Estimate

BenzingaNov 15 05:16

Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

SECNov 15 05:12